Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.

Valiengo L, Benseñor IM, Goulart AC, de Oliveira JF, Zanao TA, Boggio PS, Lotufo PA, Fregni F, Brunoni AR.

Depress Anxiety. 2013 Jul;30(7):646-53. doi: 10.1002/da.22079. Epub 2013 Apr 26.

PMID:
23625554
2.

The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.

Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, Boggio PS, Lotufo PA, Benseñor IM, Fregni F.

JAMA Psychiatry. 2013 Apr;70(4):383-91. doi: 10.1001/2013.jamapsychiatry.32.

PMID:
23389323
3.

Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study.

Martin DM, Alonzo A, Mitchell PB, Sachdev P, Gálvez V, Loo CK.

J Affect Disord. 2011 Nov;134(1-3):459-63. doi: 10.1016/j.jad.2011.05.018.

PMID:
21641047
4.

Continuation transcranial direct current stimulation for the prevention of relapse in major depression.

Martin DM, Alonzo A, Ho KA, Player M, Mitchell PB, Sachdev P, Loo CK.

J Affect Disord. 2013 Jan 25;144(3):274-8. doi: 10.1016/j.jad.2012.10.012. Epub 2012 Nov 10.

PMID:
23146197
5.

Novel Augmentation Strategies in Major Depression.

Martiny K.

Dan Med J. 2017 Apr;64(4). pii: B5338. Review.

PMID:
28385173
6.

Differential improvement in depressive symptoms for tDCS alone and combined with pharmacotherapy: an exploratory analysis from the Sertraline vs. Electrical Current Therapy for Treating Depression Clinical Study.

Brunoni AR, Júnior RF, Kemp AH, Lotufo PA, Benseñor IM, Fregni F.

Int J Neuropsychopharmacol. 2014 Jan;17(1):53-61. doi: 10.1017/S1461145713001065. Epub 2013 Sep 23.

PMID:
24060107
7.

Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial.

Brunoni AR, Schestatsky P, Lotufo PA, Benseñor IM, Fregni F.

Clin Neurophysiol. 2014 Feb;125(2):298-305. doi: 10.1016/j.clinph.2013.07.020. Epub 2013 Aug 30.

PMID:
23994192
8.

Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.

Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira EL, Valiengo L, Benseñor IM, Lotufo PA, Carvalho AF, Cho HJ, Gattaz WF, Teixeira AL.

J Affect Disord. 2015 Oct 1;185:209-13. doi: 10.1016/j.jad.2015.07.006. Epub 2015 Jul 29.

PMID:
26241865
9.

Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.

Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Vieira GP, Bueno VF, Goulart AC, Boggio PS, Lotufo PA, Bensenor IM, Fregni F.

Contemp Clin Trials. 2011 Jan;32(1):90-8. doi: 10.1016/j.cct.2010.09.007. Epub 2010 Sep 18.

PMID:
20854930
10.

Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.

Palm U, Fintescu Z, Obermeier M, Schiller C, Reisinger E, Keeser D, Pogarell O, Bondy B, Zill P, Padberg F.

J Affect Disord. 2013 Sep 5;150(2):659-63. doi: 10.1016/j.jad.2013.03.015. Epub 2013 May 7.

PMID:
23664268
11.

Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: findings from a naturalistic study.

Brunoni AR, Ferrucci R, Bortolomasi M, Scelzo E, Boggio PS, Fregni F, Dell'Osso B, Giacopuzzi M, Altamura AC, Priori A.

Eur Psychiatry. 2013 Aug;28(6):356-61. doi: 10.1016/j.eurpsy.2012.09.001. Epub 2012 Nov 23.

PMID:
23182847
12.

BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.

Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL, Vanderhasselt MA, Nitsche MA, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.

Eur Neuropsychopharmacol. 2014 Jul;24(7):1144-51. doi: 10.1016/j.euroneuro.2014.03.006. Epub 2014 Mar 27.

13.
14.

Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.

Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez AB, Fregni F, Benseñor IM.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1530-40. doi: 10.1016/j.euroneuro.2013.03.009. Epub 2013 Apr 21.

PMID:
23615118
15.

Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: a follow-up study.

Dell'Osso B, Dobrea C, Arici C, Benatti B, Ferrucci R, Vergari M, Priori A, Altamura AC.

CNS Spectr. 2014 Aug;19(4):347-54. doi: 10.1017/S1092852913000497. Epub 2013 Aug 20.

PMID:
23962405
16.

Augmenting transcranial direct current stimulation with (D)-cycloserine for depression: a pilot study.

Chan HN, Alonzo A, Martin DM, Mitchell PB, Sachdev P, Loo CK.

J ECT. 2013 Sep;29(3):196-200. doi: 10.1097/YCT.0b013e3182801b09.

PMID:
23792778
17.

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.

J Clin Psychiatry. 2006 Nov;67(11):1767-75.

PMID:
17196058
18.

Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1983-9. doi: 10.1016/j.pnpbp.2011.08.008. Epub 2011 Aug 24.

PMID:
21889560
19.

Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.

Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC.

J Clin Psychopharmacol. 2000 Dec;20(6):645-52.

PMID:
11106136
20.

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.

Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J.

J Affect Disord. 2002 Apr;68(2-3):317-30.

PMID:
12063159

Supplemental Content

Support Center